PDS Planning’s BeOne Medicines Ltd ONC Stock Holding History

PDS Planning’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$201K	Buy	+548	New	+$187K	0.01%	594

Other funds holding ONC

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Barings Charlotte, North Carolina $5.84B AUM 11.61% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

PDS Planning's ONC Position: Q3 2026 in Review

PDS Planning opened a new position in BeOne Medicines Ltd (ONC) in Q3 2026: 548 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #594 among its holdings.

135 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

PDS Planning held 548 shares of BeOne Medicines Ltd worth $201K as of Q3 2026.
BeOne Medicines Ltd was a new PDS Planning position in Q3 2026.
BeOne Medicines Ltd made up 0.01% of PDS Planning's portfolio in Q3 2026, its #594 holding.
135 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on PDS Planning's 13F filing for Q3 2026, filed 3 Nov 2026.